Effects of evolocumab therapy and low LDL‐C levels on vitamin E and steroid hormones in Chinese and global patients with type 2 diabetes

por Blom, Dirk J., Chen, Jiyan, Yuan, Zuyi, Borges, Joao L. C., Monsalvo, Maria L., Wang, Nan, Hamer, Andrew W., Ge, Junbo
Publicado 2020

Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial

por Lorenzatti, Alberto J., Eliaschewitz, Freddy G., Chen, Yundai, Lu, Juming, Baass, Alexis, Monsalvo, Maria Laura, Wang, Nan, Hamer, Andrew W., Ge, Junbo
Publicado 2019

Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical tr...

por Chen, Yundai, Yuan, Zuyi, Lu, Juming, Eliaschewitz, Freddy G., Lorenzatti, Alberto J., Monsalvo, Maria Laura, Wang, Nan, Hamer, Andrew W., Ge, Junbo
Publicado 2019

Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study

por Schubert, Jessica, Lindahl, Bertil, Melhus, Håkan, Renlund, Henrik, Leosdottir, Margrét, Yari, Ali, Ueda, Peter, James, Stefan, Reading, Stephanie R, Dluzniewski, Paul J, Hamer, Andrew W, Jernberg, Tomas, Hagström, Emil
Publicado 2020